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Treatment Options for Seizures 
Practical Points in Epilepsy Management 
Dr. Soraya Jimenez 
Lehigh Neurology 
© Lehigh Valley Health Network 
CASE ONE 
▪ 21yo male with no significant medical history, 
has a GTC seizure at 9AM in the presence of 
two fraternity brothers 
▪ Lasting 2 minutes 
▪ He remained sleepy and confused for 30 
minutes, then returned to baseline 
▪ Normal neurological and general exam, except 
for an abrasion of the right side of the tongue 
▪ CBC, CMP, Tox screen, EKG are normal 
 THE FIRST UNPROVOKED 
SEIZURE 
▪ To treat or not to treat? 
THE FIRST UNPROVOKED SEIZURE 
▪ Approximately 10% of the population will 
have at least one seizure at some point in 
their life 
▪ Half of these will occur during childhood 
and adolescence 
▪ The highest risk is before age 1  
▪ The higher prevalence of unprovoked 
seizures is in patients younger than 1 year  
and older than 65 years 
RECURRENCE RISK 
FIRST study 
 Untreated subjects 
▪ 18% at 3 months 
▪ 28% at 6 months 
▪ 41% at 12 months 
▪ 51% at 24 months 
Neurology 1993; 43; 478-483 
RECURRENCE RISK 
 MESS study  
▪ 722 treated / 721 deferred  
▪ Untreated arm recurrence risk  
•6 months 26%  
•2 years   39% 
•5 years  51%  
•8 years  52% 
Lancet 2005; 365: 2007-13 
PREDICTORS OF A FIRST 
SEIZURE RECURRENCE 
▪ The risk of a recurrence is highest during 
the period immediately after initial seizure 
▪ There is no algorithm to predict with 
absolute certainty who will or will not have 
a recurrence and when that recurrence will 
occur 
▪ What can be summarized today is very 
much the same as reported in reviews of 
this same topic written over 10 years ago  
RECURRENCE RISK 
▪ The observational studies taken as a 
whole, provide an estimate of the 2 year 
recurrence risk in the range of 40% 
▪ The majority of recurrence occur early with 
approximately 50% within 6 months of the 
initial seizure 
▪ Studies with prolonged follow up periods 
show that 80-90% of individuals who recur 
do so within 2 years of the initial seizure 
 
 
PREDICTORS OF A FIRST 
SEIZURE RECURRENCE 
     Consistently associated with an increased risk of 
recurrence in both children and adults: 
 
1. Abnormal EEG (Epileptiform abnormality)  
2. Symptomatic cause or abnormal 
neurological exam    
EEG 
▪ The diagnostic yield of EEG in the 
presence of a first seizure is substantial 
▪ 50% of the patients on average have 
abnormal tracings 
▪ An EEG done in the first 24 hours after a 
seizure has a greater probability of 
detecting epileptiform abnormalities 
CASE ONE 
▪ Normal neurological exam 
▪ Normal EEG 
▪ Normal MRI brain 
▪ No risk factors by history 
▪ NOT TO TREAT 
▪ When to treat 
• Patient preference  
• Two years 
• Repeat studies 
CASE ONE 1B 
▪ Positive Babinski sign on the right 
▪ Normal MRI brain 
▪ No risk factors  
▪ Drives a Forklift 
▪ No driving for 6 months 
▪ No treatment 
▪ Recurred exactly at 6 months 
CASE 2 
▪ 15 year old female  
▪ With recurrent episodes of 
unresponsiveness 
▪ Staring straight ahead 
▪ Associated with lip smacking  
▪ Lasting 2-5 minutes 
CASE 2 
▪ Partial seizures 
▪ Abnormal MRI 
▪ ? Febrile seizures as a child 
MESIAL TEMPORAL SCLEROSIS 
WOMENS TREATMENT RELATED 
ISSUES 
MANAGEMENT ISSUES FOR 
WOMEN WITH EPILEPSY 
▪ Management of women with epilepsy has 
specific challenges 
▪ Hormonal influence on seizures 
▪ Interaction of AEDs w contraceptives 
▪ Effect of AEDs on bone health 
 
MANAGEMENT ISSUES FOR 
WOMEN WITH EPILEPSY 
▪ Potentially 1 million WWE of childbearing 
age in USA 
▪ 3-5 births per thousand will be to WWE 
▪ Issues in women w/ epilepsy who take 
AEDs during their reproductive years are 
numerous and complex 
MANAGEMENT ISSUES FOR 
WOMEN WITH EPILEPSY 
Improve: 
▪ Family planning  
▪ Seizure management 
▪ Pregnancy outcomes 
▪ Patient satisfaction  
CATAMENIAL SEIZURES 
CATAMENIAL SEIZURES 
▪ Lacks a standard definition 
▪ Reported to occur in 10-70% of women at 
risk 
▪ Estrogens inhibits GABA mediated 
inhibition and potentiates glutamate 
mediated excitation 
▪ Resulting in heightened excitability 
▪ Increased interictal spikes and seizures 
 
CATAMENIAL SEIZURES 
▪ Progesterone opposite effect 
▪ Potentiates barbiturate like ligands at the 
GABA channel 
▪ Reducing interictal epileptiform discharges 
▪ Fewer seizures 
CATAMENIAL SEIZURES 
 
▪ During the follicular 




▪ Second phase of the 
cycle Progesterone 
predominates 
Image(s) have been 
omitted 
CATAMENIAL SEIZURES 
▪ During ovulatory cycles most seizures 
occur approx. 3 days before onset of 
menses 
▪ Persists for about 6 days 
▪ These seizures appear to be triggered by 
progesterone withdrawal 
▪ Seizures may also occur at ovulation, 
precipitated by estrogen surge 
CATAMENIAL SEIZURES 
▪ In anovulatory cycles seizures are more 
frequent and dispersed = estrogen remains 
high and progesterone low 
▪ 10% of menstrual cycles in healthy women 
are anaovulatory 
▪ 35% are anovulatory in women with 
temporal lobe epilepsy 
 
CATAMENIAL SEIZURES 
▪ Chart menses along w/ seizures for at 
least 4 months 
▪ A day 22 progesterone level (day 1 is the 
onset of bleeding) < 5ng/mL indicates 
inadequate luteal phase 
▪ Distinct pattern = Catamenial seizures = 




▪ First line treatment: The most effective 
AED monotherapy 
▪ Supplemental daily dose of maintenance 
AED at the time of expected seizure 
exacerbation 
▪ 2-3 days before the expected cluster  




▪ Diamox (off label) 250-1000 mgs in two 
divided doses 
▪ Tolerance = Intermittent therapy 
▪ 10-14 days around the time of seizure 
vulnerability 




▪ Any treatment with hormonal manipulation 
should be done in collaboration w/ a GYN 
▪ Oral synthetic Progestins not helpful 
▪ Parenteral medroxyprogesterone (Depo-
Provera) given in large enough doses to 
cause amenorrhea = reduction in seizure 
frequency in some women 
CATAMENIAL SEIZURES 
▪ Natural Progesterone (extract of soy in 
suppository and Lozenge form) over the 
initial luteal phase of the cycle 100-200 
mgs TID or QID 
▪ Prometrium 100 mg capsules 
▪ Progesterone topical cream 
▪ Avoided in anticipation of a pregnancy and 
in the absence of contraception 
 
CATAMENIAL SEIZURES 
▪ Antiestrogens: Clomiphene 
▪ Reported to reduce seizures in women w/ 
intractable partial epilepsy 
▪ Side effects:  
– Hot flashes  
– Polycystic ovaries 
– Unplanned pregnancy  
– Breast tenderness 
– Ovarian overstimulation syndrome 
CATAMENIAL SEIZURES 
▪ Women with catamenial seizure pattern 
may experience improved seizure control 
after menopause 
▪ During perimenopause = Irregular Cycles = 
Fluctuation in gonadal steroids = 
Worsened seizure frequency 
▪ Postmenopausal estrogen replacement 
may exacerbate seizures in some WWE 
CONTRACEPTION 
CONTRACEPTION 
▪ Taken in combination with hepatic 
cytochrome p450 enzyme inducing AED 
can be ineffective 
▪ 6% per year failure rate of oral 
contraceptives in women taking hepatic 
enzyme inducing AEDs 
CONTRACEPTION 
▪ Standard prescribed oral contraceptives 
contain only minimal dosage of hormones 
▪ Even small increases in metabolism lead 
to contraceptive failure 
CONTRACEPTION 
▪ Levonorgestral (Norplant; progestin only 
formulation) implants not a good 
alternative if using enzyme inducing AEDs, 
efficacy is reduced.  
▪ IM medroxyprogeterone (Depo Provera) 
higher dosages of progestin has not yet 
been evaluated for effectiveness in WWE 
 
CONTRACEPTION 
▪ The effectiveness of hormonal 
contraception in the context of enzyme 
inducing AEDs remains at approximately 
the same level as that of IUDs and is 
superior to barrier methods of birth 
control 
▪ Formulations containing at least 50ug of 
estradiol or mestranol are more protective 












DO NOT INTERACT 













AEDs USE IN PREGNANCY 
AEDs USE IN PREGNANCY 
▪ 20,000 WWE become pregnant each year 
▪ Seizure frequency may change during 
pregnancy 
▪ 35% experience increase in seizure 
frequency 
▪ 55% have no change 
▪ 10% decrease in seizure frequency 
AEDs USE IN PREGNANCY 
▪ AED concentrations may change during 
pregnancy 
▪ Decreased gastric tone and motility 
▪ Increase plasma volume 
▪ Increase in renal clearance 
▪ Albumin levels and protein binding decline 
= Increase in free level 
 
AEDs USE IN PREGNANCY 
▪ AED most appropriate for seizure type and the 
drug producing optimal control with least side 
effects remains the AED of choice for WWE 
▪ AEDs are human teratogens 
▪ A specific syndromes are no longer accepted 
▪ Fetal AED syndrome is more appropriate 
AEDs USE IN PREGNANCY 
▪ 90% of children born from of women with 
epilepsy will be normal 
▪ Fertility rate 25-33% lower than average 
▪ There is no risk free anticonvulsant 
▪ Major malformations occurs in 2-3 % of all 
live born children 






AEDs USE IN PREGNANCY 
Minor congenital malformations 
▪ Facial dysmorphism 
▪ Digital anomalies  
▪ 6-20% infants exposed to AEDs 
▪ Two-fold increase over the general 
population 
▪ Subtle and outgrown 
 
AEDs USE IN PREGNANCY 
Major malformations  
▪ Cleft lip and palate 
▪ Cardiac defects 
▪ Urogenital defects 
▪  4-6% of infants born to mother w/ epilepsy 
and taking older AEDs  
▪ 2-4% general population 
AEDs USE IN PREGNANCY 
▪ Multiple AEDs at higher risk for congenital 
malformations and developmental delay 
▪ Higher mean AED concentrations 
associated with increased malformation 
risk 
▪ If WWE have been free of seizures on an 
AED for a period of time, discussion 




AEDs USE IN PREGNANCY 
▪ Discontinuation of AEDs may be 
considered: 
•Patient seizure free 2-5 years  
•Single type of seizure 
•Normal neurological examination and IQ 
•EEG normalized with treatment 
AEDs USE IN PREGNANCY 
▪ Risk for seizure recurrence is cumulative 
but greatest in the first 6 months after 
discontinuing AEDs 
▪ It is desirable, therefore, that AED 
withdrawal be completed at least 6 months 




AEDs USE IN PREGNANCY 
▪ A planned pregnancy would be ideal 
▪ Major risk of malformation is within the first 
trimester 
▪ No changes to be made after that unless 
optimization of the regimen is necessary 
AEDs USE IN PREGNANCY 
▪ Optimize AED before pregnancy 
▪ Counseling about compliance 
▪ Monitoring non-protein-bound AED levels 
▪ Seizures well controlled with monotherapy 
= no change 
▪ Changes in AEDs during pregnancy to 
reduce teratogenicity  is contraindicated 
AEDs USE IN PREGNANCY 
▪ MD usually involved after few weeks of 
pregnancy 
▪ At that point limited advantage to change 
▪ Overlapping AEDs during change exposes 
the fetus to the effect of an additional AED 
AEDs USE IN PREGNANCY 
▪ No consensus for frequency of AED monitoring  
▪ Total AEDs levels fall throughout pregnancy 
▪ Free (non protein bound) level remain constant 
▪ Baseline preconception free level 
▪ Repeat at the beginning of each trimester and 
last 4 weeks of pregnancy 
▪ AED change or dosage remains clinical based 
on seizure occurrence or adverse effects 
 
AEDs USE IN PREGNANCY 
▪ Risk for poor pregnancy outcome with 
optimal care is not a contraindication for 
pregnancy 
▪ Over 90% will have a good pregnancy 
outcome 
▪ A minority will have worsening of seizure 
control during pregnancy 
AAN Practice Parameters Update 
Focus on Pregnancy (2009) 
▪ Probable WWE  taking AEDs no 
substantial increased risk for Cesarean 
delivery (moderate?) 
▪ No increased risk of premature 
contractions/labor/delivery 
▪ But increased for WWE who smoke 
AAN Practice Parameters Update 
Focus on Pregnancy (2009) 
▪ If seizure free 9-12 months prior pregnancy 
84-92% are going to be seizure free 
CASE 2 
▪ 15 year old female  
▪ With recurrent episodes of 
unresponsiveness 
▪ Staring straight ahead 
▪ Associated with lip 
smacking  
▪ Lasting 2-5 minutes 
▪ Partial seizures 
▪ MRI Mesial Temporal 
Sclerosis 















DO NOT INTERACT 













FOLIC ACID SUPPLEMENTATION 
▪ PHE, CBZ, and barbiturates can impair folate 
absorption 
▪ Pre-pregnancy and early pregnancy 
supplementation with folic acid for WWE during 
reproductive years is recommended 
▪ Folic acid supplementation reduces primary and 
secondary risk for neural tube defects in infants 
of women who do not take AEDs 
FOLIC ACID SUPPLEMENTATION 
▪ Optimal dose is unclear, because study 
supplementation has varied between 0.36-
5 mgs/day 
▪ Folic acid supplementation no less than 




▪ 17 year old male evaluated with a first 
GTC seizure 
▪ Occurred in the morning shortly after 
waking up 
▪ Preceded by myoclonic jerks of arms 
▪ Neurological and general exam are normal 
▪ Blood work and MRI of the brain with 
gadolinium were normal 
BONE HEALTH 
▪ People with epilepsy have a higher rate of 
broken bones than people who do not 
have seizures 
▪ Fractures are 2-6 times more frequent in 
patients with epilepsy compared to the 
general population 
BONE HEALTH 
▪ Enzyme inducing AEDs: Phenytoin, 
Phenobarbital, Primidone are associated 
with decreased Bone Mineral Density 
▪ Carbamazepine increases bone turnover 
▪ Enzyme inducing agents demonstrate 
•Lower vitamin D levels  




Severity may be correlated with: 
▪ Duration of AED exposure 
▪ Number of AEDs used 
▪ Type of AEDs used 
▪ Inducers of cytochrome P450 most commonly 





– Possibly VPA 
 
BONE HEALTH 
▪ AEDs may decrease bone mineral density 
▪ Alter bone mineral metabolism 
▪ Women in particular are vulnerable to the 
effects of AEDs on bone health 
▪ Women taking AEDs are two times more 
likely to have hip fracture (study women 
older 65) 
BONE HEALTH 
▪ In women with epilepsy osteoporosis 
appears to be more prevalent 
▪ Occurs at younger age 
 
Progressive bone deficit in 
epilepsy  
▪ A cross-sectional evaluation  
▪ 82 ambulatory children aged 6 to 18 years  
▪ With epilepsy for <1 year to  6 or more 
years (n = 27) 
▪ Controls were 32 healthy children aged 
12.8 
 
 2.6 years 
Neurology, January 2008; 70:170-176 
Progressive bone deficit in 
epilepsy 
▪ Children with epilepsy had reduced total 
body mean bone mineral density 
compared with control 
▪ Increasing duration of epilepsy was 
associated with a reduction in total bone 
mineral density 
▪ Boys < I year of epilepsy higher bone 
density than girls 
Progressive bone deficit in 
epilepsy 
▪ > 6 or more years of epilepsy girls had 
higher bone density compared with boys 
▪ Both boys and girls  with epilepsy are at 
risk for lower bone density 
▪ The study was not powered to determine 
individual antiepileptic medication effects 
on bone mineral density 
BONE HEALTH 
▪ All patients with epilepsy should receive 
adequate daily CA and vitamin D 
▪ Regular exercise gravity resisting 
▪ All menopausal women and patients with 
prolonged AED use (>5 years), should 
have a DEXA scan 
BONE HEALTH 
Bone disease is increased:  
▪ With history of enzyme inducing AEDs 
exposure 
▪ Polypharmacy 
▪ Longer duration of treatment 
BONE HEALTH 
▪ Significant declines in bone density can be 
seen 1 year after initiation of AEDs 
▪ The appropriate timing for the first screen 
or interval for subsequent follow up is 
unknown 
▪ Some suggest to screen for patients on 
AEDs for 2-5 years 
EPILEPSY AND ALCOHOL 
▪ Moderate alcohol consumption is not associated with 
increased seizure activity 
▪ Binge drinking and alcohol withdrawal can cause 
seizures and even status epilepticus  
▪ A drink or two now and then does not increase seizure 
activity 
▪ When alcohol is related to seizures, usually are 
secondary alcohol withdrawal rather than drinking itself.  
▪ Alcohol withdrawal seizures 6 and 72 hours after the last 
drink 
▪ Risk of seizures is increased after three or more alcoholic 
beverages 
EPILEPSY AND EXERCISE 
▪ Aerobic  
▪ Walking 
▪ Jogging, running (especially on an indoor, grass, or 
supervised track)  
▪ Stationary bicycling (recumbent bicycle) are particularly 
safe  
▪ Treadmills are generally safe (emergency stop)  
▪ Elliptical or similar devices are probably preferable to 
treadmills 
▪ Exercise benefits individuals with epilepsy: including 
improved seizure control, mood, and quality of life 
▪ No significant evidence to suggest that contact sports are 
harmful to athletes with epilepsy 
CASE 3 
▪ 17 year old male evaluated 
with a first GTC seizure 
▪ Occurred in the morning shortly 
after waking up 
▪ Preceded by myoclonic jerks of 
arms 
▪ Neurological and general exam 
are normal 
▪ Blood work and MRI of the 
brain with gadolinium were 
normal 






▪ Carbamazepine !!! 



















ALWAYS DISCUSS SEIZURE 
PRECAUTIONS 
KEEP AN EYE ON THE GOAL 
 GOALS OF THE TREATMENT 
–Seizure freedom 
–Good quality of life 
–No side effects 
